XOMA company info

What does XOMA do?
XOMA (NASDAQ:XOMA) is a biotech entity focused on the discovery and development of innovative antibody-based therapeutics. The company’s operations revolve around licensing its extensive portfolio of patents and clinical development products to other biotechnology and pharmaceutical companies. XOMA's projects often involve developing partnerships and collaborations to advance the research and development of drugs with the potential to address a wide range of diseases and conditions. The primary objective of XOMA is to leverage its proprietary technology and scientific expertise to create a robust pipeline of therapeutic candidates, which provides the foundation for future growth and innovation in the medical field.
XOMA  company media
Company Snapshot

Is XOMA a public or private company?

key
Ownership
Public

How many people does XOMA employ?

people
Employees
13

What sector is XOMA in?

pie chart
Sector
Health Care

Where is the head office for XOMA ?

location pin
Head Office
Emeryville, United States

What year was XOMA founded?

founded flag
Year Founded
1981
What does XOMA specialise in?
/Biopharmaceutical Company /Drug Discovery /Monoclonal Antibodies /Disease Treatment /XOMA 358 /Immunological Diseases

What are the products and/or services of XOMA ?

Overview of XOMA offerings
Royalty Agreements Management, generating revenue through a portfolio of partnered assets and milestone payments.
License XOMA 358, an insulin receptor modulator for hyperinsulinism disorders.
License Gevokizumab, targeting IL-1 beta for inflammatory conditions.
Out-licensing Technologies, providing proprietary technologies to partners for drug development.
Phage Display Libraries for antibody discovery and development, offering partners tools for novel therapeutics.
Partnered Discovery Projects, collaborating on the identification and development of early-stage drug candidates.

Who is in the executive team of XOMA ?

XOMA leadership team
  • Mr. Owen P. Hughes Jr.
    Mr. Owen P. Hughes Jr.
    CEO & Director
  • Mr. Thomas M. Burns
    Mr. Thomas M. Burns
    Senior VP of Finance & CFO
  • Mr. Brad  Sitko
    Mr. Brad Sitko
    Chief Investment Officer